Normalvy
MARC-vy
Drug involvement in fatal crashes in Melbourne Hendtlass, Jane
Utgivningsinformation: Melbourne Australian Department of Transport, 1985; Office of Road Safety. CR 41, Beskrivning: 196 sÄmnen: Bibl.nr: VTI P0643:41 VTI 2002.0734:3Location: Abstrakt: Information about drug use was collected from drivers and pedestrians involved in road crashes in Melbourne in which a driver or pedestrian was killed. This involved analysis of body fluid from 191 fatalities combined with other information about drug use from police files. 44% had used drugs other than alcohol, caffeine and nicotine. Among fatalities, 55% of drivers or riders in single vehicle crashes, 77% of drivers or riders in multivehicle crashes and 61% of pedestrians had used drugs. Cannabis was the most frequently detected drug other than alcohol, caffeine and nicotine, followed by aspirin.| Omslagsbild | Exemplartyp | Aktuellt bibliotek | Hembibliotek | Avdelning | Hyllplacering | Hyllsignatur | Specificerade material | Volyminfo | URL | Ex.nummer | Status | Kommentarer | Förfallodatum | Streckkod | Exemplarreservationer | Köplats för exemplarreservation | Kurslistor | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statens väg- och transportforskningsinstitut | Tillgänglig | |||||||||||||||||
| Statens väg- och transportforskningsinstitut | Tillgänglig | |||||||||||||||||
| Statens väg- och transportforskningsinstitut | Tillgänglig |
Information about drug use was collected from drivers and pedestrians involved in road crashes in Melbourne in which a driver or pedestrian was killed. This involved analysis of body fluid from 191 fatalities combined with other information about drug use from police files. 44% had used drugs other than alcohol, caffeine and nicotine. Among fatalities, 55% of drivers or riders in single vehicle crashes, 77% of drivers or riders in multivehicle crashes and 61% of pedestrians had used drugs. Cannabis was the most frequently detected drug other than alcohol, caffeine and nicotine, followed by aspirin.